Job Description
Grow your career at Cedars-Sinai! The Smidt Heart Institute reflects Cedars-Sinais steadfast dedication to heart disease and research innovation, giving patients access to the highest level of care. Year after year, thousands of people trust their hearts to Smidt Heart Institute at Cedars-Sinai. Our cardiologists, cardiac surgeons, and specialized care teams treat the full spectrum of heart disease and disorders, while our investigators continue to advance the field with groundbreaking, life-saving research. From genetic counseling and targeted drug therapies to a growing array of minimally invasive procedures, Cedars-Sinai continues to stand at the forefront of technology, innovation, and discovery, improving patient outcomes. Join our team and use your skills with an organization known nationally for excellence in research!
Our T-32 Cardiovascular Research Fellowship at Cedars-Sinai Smidt Heart Institute is a robust post-doctoral training program that prepares individuals for productive and fulfilling careers within cardiovascular research. It fosters the development of PhD and physician investigators who require rigorous formal training to translate basic and clinical research to the clinical practice of cardiovascular medicine.
The fellowships proven success is based on an approach comprised of three collaborative components: education, mentorship, and hands-on research. The program is under the leadership of Eduardo Marban, MD, PhD, Mark Siegel Family Foundation Distinguished Professor, Executive Director, Smidt Heart Institute, and Joshua I. Goldhaber, MD, Dorothy and E. Phillip Lyon Chair in Laser Research.
The fellowship program is supported by more than 20 principal investigators and support staff, resulting in a robust foundation for training.
Program Training and Success of Graduates
Trainees will select one principal investigator as mentor and will then be assigned a complimentary clinical or basic science mentor as part of our team-based mentoring system. Basic course work in statistics, responsible conduct in research, and research methodology is required depending upon previous education. Ongoing research in the principal investigators laboratory will culminate in submission of a career development award (K award or equivalent) by the end of two years. The possibility of extension is based on productivity and research.
Previous trainees have attained faculty positions in academic institutions as well as leadership positions in industry.
Qualifications
Educational Requirements:
The successful candidates (MD, MD/PhD, PhD, or equivalent) will either have relevant basic science training and a desire to learn how to apply basic science principles to translational cardiovascular research, or clinical and/or health services research training related to cardiovascular disease and a desire to gain additional expertise in research methodology.
At this time, we can only accept applicants who are U.S. citizens or permanent residents. PhD candidates must also be within three years of receiving their degree, and MD candidates must be within one year of completing their clinical training.
Experience
Strong research lab experience is required. In order to qualify for the role, you must be a U.S. citizen or U.S. resident.
Physical Demands
Standing, lifting, sitting for periods of time.
Cedars Sinai is one of the largest nonprofit academic medical centers in the United States, and it is the largest private academic medical center in the Western United States. The Cedars Sinai main campus, which encompasses nearly 24 acres, is located at the point where the cities of Los Angeles, Beverly Hills, and West Hollywood meet. Cedars Sinai has been recognized annually by U.S. News & World Report’s top 10 best hospitals in the U.S. The institution most recently placed No. 7 among a select group of 20 Honor Roll hospitals and ranked nationally in a dozen specialties. In addition, Cedars Sinai ranked No. 3 in California and No. 2 in the Los Angeles metro area.
Within Cedars Sinai, the Institute for Research on Health Aging conducts multi-disciplinary research that prioritizes the prevention of cardiovascular disease, neurocognitive disease, and cancer. Our focus is on translating new research discoveries into pragmatic interventions aimed at promoting healthy aging across diverse populations. Our approach involves human physiology, cohort, and clinical trial studies and our team includes established experts in population, clinical, translational, basic, and data science.